Journal of Neurology and Neurorehabilitation Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Opinion Article - Journal of Neurology and Neurorehabilitation Research (2024) Volume 9, Issue 4

Autoimmune Encephalitis in Pediatrics: Recognition and Treatment Protocols

Patrick Dalmau *

Department of Neurology, Kitasato University School of Medicine, Japan

*Corresponding Author:
Patrick Dalmau
Department of Neurology, Kitasato University School of Medicine, Japan
E-mail: cushing@uc.us.in

Received: 27-Jun-2024, Manuscript No. JNNR-24-144125; Editor assigned: 28-Jun-2024, PreQC No. JNNR-24-144125(PQ); Reviewed: 12-July-2024, QC No. JNNR-24-144125; Revised: 17-Jul-2024, Manuscript No. JNNR-24-144125(R); Published: 26-Jul-2024, DOI: 10.35841/aajnnr-9.4.217

Citation: : Dalmau P. Autoimmune encephalitis in pediatrics: Recognition and treatment protocols. J Neurol Neurorehab Res.2024;9(4):217

Introduction

Autoimmune encephalitis in pediatrics is a complex and challenging condition characterized by inflammation of the brain caused by the body’s immune system mistakenly attacking its own brain tissues. This condition can present with a diverse array of symptoms and requires a comprehensive approach for recognition and treatment. Early diagnosis and intervention are critical to improving outcomes and minimizing long-term impacts [1].

Recognition of autoimmune encephalitis in children can be particularly challenging due to its variable presentation and the overlap of symptoms with other neurological and psychiatric disorders. Symptoms often include seizures, changes in behavior or personality, cognitive decline, movement disorders, and autonomic instability [2]. These manifestations can range from subtle to severe, making it essential for clinicians to consider autoimmune encephalitis in the differential diagnosis of any child presenting with new-onset seizures, neuropsychiatric symptoms, or unexplained neurological deterioration [3].

The diagnostic process typically involves a combination of clinical evaluation, neuroimaging, and laboratory testing. Magnetic Resonance Imaging (MRI) of the brain may reveal characteristic patterns of inflammation or injury, but findings can be variable and may not always be diagnostic. Cerebrospinal fluid (CSF) analysis is crucial and may show elevated protein levels, increased white blood cells, and, in some cases, the presence of specific autoantibodies [4]. Serological tests and autoimmune panels are essential for identifying the presence of autoantibodies against neuronal cell surface or intracellular antigens, which are indicative of autoimmune encephalitis. These antibodies include anti-NMDA receptor, anti-LGI1, anti-Caspr2, and others, depending on the specific autoimmune etiology [5].

Electroencephalography (EEG) is another important tool in the evaluation of autoimmune encephalitis. It can reveal epileptiform activity or diffuse slowing, which can be indicative of the underlying inflammation and its impact on brain function. However, EEG findings alone are not sufficient for a definitive diagnosis and should be interpreted in conjunction with clinical and laboratory data [6].

The treatment of autoimmune encephalitis in pediatrics involves a multi-faceted approach, including immunotherapy, symptomatic management, and supportive care. The cornerstone of treatment is immunotherapy, which aims to reduce inflammation and modulate the immune response [7]. First-line treatments typically include corticosteroids, such as prednisone or methylprednisolone, which help to control acute inflammation. In cases where corticosteroids alone are insufficient, additional immunotherapies such as intravenous immunoglobulin (IVIG) or plasmapheresis may be used to further target the autoimmune process [8].

Early and ongoing multidisciplinary care is critical for optimizing outcomes in pediatric autoimmune encephalitis. This approach often involves a team of specialists, including neurologists, immunologists, psychiatrists, and rehabilitation therapists, working together to address the complex needs of the child. Regular follow-up and monitoring are necessary to assess treatment efficacy, manage side effects, and make adjustments to the therapeutic plan as needed [9].

Prognosis varies depending on the specific type of autoimmune encephalitis, the severity of the initial presentation, and the timeliness and effectiveness of treatment. Some children may experience significant improvement and recovery with appropriate treatment, while others may have persistent cognitive, behavioral, or neurological deficits [10].

Conclusion

Autoimmune encephalitis in pediatrics is a serious condition that requires prompt recognition and a comprehensive treatment approach. The diagnosis involves a careful evaluation of clinical symptoms, neuroimaging, CSF analysis, and serological testing. Treatment typically includes immunotherapy, symptomatic management, and supportive care, with the goal of reducing inflammation, controlling symptoms, and improving functional outcomes. A multidisciplinary approach is essential for addressing the complex needs of affected children and optimizing their recovery and long-term well-being.

References

  1. Wright MA, Trandafir CC, Nelson GR, et al. Diagnosis and management of suspected pediatric autoimmune encephalitis: a comprehensive, multidisciplinary approach and review of literature. J Child Neurol. 2022;37(4):303-13.

    2. Indexed at, Google Scholar, Cross Ref

  2. Dale RC. Autoimmune encephalitis: overview of clinical recognition, autoantibody diagnostic markers, and treatment of autoimmune encephalitis. Nagakute, Japan: Elsevier. 2017:123-32.

    3. Google Scholar

  3. Broadley J, Seneviratne U, Beech P, et al. Prognosticating autoimmune encephalitis: a systematic review. J Autoimmun. 2019;96:24-34.

    4. Indexed at, Google Scholar, Cross Ref

  4. Wright S, Vincent A. Pediatric autoimmune epileptic encephalopathies. J Child Neurol. 2017;32(4):418-28.

    5. Indexed at, Google Scholar, Cross Ref

  5. Pretkalnina D, Grinvalde S, Kalnina E. Pediatric Autoimmune Encephalitis: A Nationwide Study in Latvia. Neuropediatrics. 2024.

    6. Indexed at, Google Scholar, Cross Ref

  6. McKeon A, Zekeridou A. Autoimmune encephalitis management: MS centers and beyond. Mult Scler. 2020;26(13):1618-26.

    7. Indexed at, Google Scholar, Cross Ref

  7. Hickox T, Brahmbhatt K, Smith JR, et al. CL Case Conference: Systemic challenges in management of aggression in a pediatric patient with seronegative autoimmune encephalitis. J Acad Consult Liaison Psychiatry. 2023.

    8. Indexed at, Google Scholar, Cross Ref

  8. Singh TD, Fugate JE, Rabinstein AA. The spectrum of acute encephalitis: causes, management, and predictors of outcome. Neurology. 2015;84(4):359-66.

    9. Indexed at, Google Scholar, Cross Ref

  9. Yeshokumar AK, Gordon-Lipkin E, Arenivas A, et al. Neurobehavioral outcomes in autoimmune encephalitis. J Neuroimmunol. 2017;312:8-14.

    10. Indexed at, Google Scholar, Cross Ref

  10. Cole J, Evans E, Mwangi M, et al. Acute disseminated encephalomyelitis in children: an updated review based on current diagnostic criteria. Pediatr Neurol. 2019;100:26-34.

    11. Indexed at, Google Scholar, Cross Ref

Get the App